Yong-June Kim, Hyung-Yoon Yoon, Ji Sang Kim, Ho Won Kang, Byung-Dal Min, Seon-Kyu Kim, Yun-Sok Ha, Isaac Yi Kim, Keun Ho Ryu, Sang-Cheol Lee and Wun-Jae Kim HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array-based DNA methylation and expression profiling International Journal of Cancer 133
Many patients with non-muscle invasive bladder cancer (NMIBC) are at high risk of disease recurrence and progression after primary treatment. Clinicians thus have to develop both cost-effective, non-invasive surveillance protocols for low-risk patients and more aggressive approaches to identify high-risk refractory cancers. This study used microarray-based methylation and expression profiling to identify novel prognostic methylation markers associated with clinicopathological tumor characteristics and disease outcomes. The presented candidate genes are the first methylation-based prognostic indicators for NMIBC. Epigenetic markers could be valuable tools for stratifying heterogeneous bladder cancer patient populations into risk groups, which in turn could help guide clinical decisions.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf